Ferring Innovation Grants for Racial Equality in Reproductive Medicine and Maternal Health
Opens Apr 28 2021 00:00 (CEST)
Deadline Jul 1 2021 23:59 (CEST)
Description

Welcome to the Ferring Innovation Grants Programme for Racial Equality in Reproductive Medicine and Maternal Health.


As a leader in Reproductive Medicine and Maternal Health, Ferring is determined to play our part in reducing racial disparities in maternal mortality and to improving in vitro fertilization (IVF), pregnancy and post-partum outcomes for Black communities, Indigenous communities and all communities of colour.


Overview of the Ferring Innovation Grants Programme for Racial Equality in Reproductive Medicine and Maternal Health


Programme Objectives

At Ferring, we are committed to building families and helping people live better lives. At the core of Ferring’s mission is our work to deliver better outcomes at every stage of the reproductive journey, from conception to birth.  As part of that commitment, Ferring is launching a new grants programme to better understand and, ultimately, drive solutions to tackle racial disparities in Reproductive Medicine and Maternal Health. 


The Ferring Innovation Grants Programme for Racial Equality in Reproductive Medicine and Maternal Health aims to fund multidisciplinary research projects across four main areas: 


1. Basic and translational research: research to further understanding of the reproductive and maternal health conditions that disproportionally affect Black communities, Indigenous communities and all communities of colour, and result in a higher risk of morbidity or mortality. Conditions of interest include, but are not limited to; infertility, polycystic ovarian syndrome (PCOS), uterine fibroids, gestational hypertension, preeclampsia, preterm birth, cardiomyopathy and other cardiovascular conditions associated with maternal death, and post-partum haemorrhage (PPH). 


2. Clinical research: research into the services available and clinical care of Black communities, Indigenous communities and all communities of colour during infertility diagnosis, IVF treatment outcome, pregnancy, birth and post-partum (fourth trimester care) - including research into interventions aiming to reduce the impact of unconscious bias in clinic care settings. Research proposals in this track should reflect the importance of the patient perspective in study design. 


3. Epidemiology and prevention research; epidemiological studies, including social, lifestyle, exposure and behavioural studies, seeking to understand the origins of racial disparities in IVF access and outcome, pregnancy and maternal health outcomes and ultimately drive solutions to tackle disparities in these areas. 


4. Social science research: Including but not limited to political, policy and human rights research exploring the structural factors that impact on Black communities, Indigenous communities and all communities of colour that contribute to lower than expected outcomes of assisted reproductive technologies (ART), pregnancy and overall maternal and post-partum health, including the barriers to participation in clinical trials. Research proposals in this track should reflect the importance of the patient perspective in study design.


In addition, projects across all research areas exploring racial disparities in COVID-19 infection, hospitalization and health outcomes during pregnancy and birth are also welcomed.


Who should apply?

We encourage submissions from researchers and research organisations around the world who are committed to reducing racial disparities in Reproductive Medicine and Maternal Health. 


Ferring Pharmaceuticals is committed to creating a diverse community and an inclusive culture which embraces, respects and values different perspectives and backgrounds. We encourage researchers from diverse backgrounds to submit applications to the Ferring Innovations Grants Programme for Racial Equality in Reproductive Medicine and Maternal Health. 


Available Funding 

The program will provide a limited number of research grants of up to EUR 20,000 per research project. 


Intellectual Property and license to data and results

Ferring does not intend to claim intellectual property on these grants. Ownership to data and results is assumed by the grant recipient and may be subject to the policies of the grant recipient’s institution. Ferring will be and is hereby granted a worldwide, non-exclusive, royalty-free, right and license (with the right to sublicense) to access, refer to, and otherwise use any and all anonymized research data, information, and other results generated as part of the project (collectively “the Results”) for internal educational, research and development purposes.

Ferring Innovation Grants for Racial Equality in Reproductive Medicine and Maternal Health


Welcome to the Ferring Innovation Grants Programme for Racial Equality in Reproductive Medicine and Maternal Health.


As a leader in Reproductive Medicine and Maternal Health, Ferring is determined to play our part in reducing racial disparities in maternal mortality and to improving in vitro fertilization (IVF), pregnancy and post-partum outcomes for Black communities, Indigenous communities and all communities of colour.


Overview of the Ferring Innovation Grants Programme for Racial Equality in Reproductive Medicine and Maternal Health


Programme Objectives

At Ferring, we are committed to building families and helping people live better lives. At the core of Ferring’s mission is our work to deliver better outcomes at every stage of the reproductive journey, from conception to birth.  As part of that commitment, Ferring is launching a new grants programme to better understand and, ultimately, drive solutions to tackle racial disparities in Reproductive Medicine and Maternal Health. 


The Ferring Innovation Grants Programme for Racial Equality in Reproductive Medicine and Maternal Health aims to fund multidisciplinary research projects across four main areas: 


1. Basic and translational research: research to further understanding of the reproductive and maternal health conditions that disproportionally affect Black communities, Indigenous communities and all communities of colour, and result in a higher risk of morbidity or mortality. Conditions of interest include, but are not limited to; infertility, polycystic ovarian syndrome (PCOS), uterine fibroids, gestational hypertension, preeclampsia, preterm birth, cardiomyopathy and other cardiovascular conditions associated with maternal death, and post-partum haemorrhage (PPH). 


2. Clinical research: research into the services available and clinical care of Black communities, Indigenous communities and all communities of colour during infertility diagnosis, IVF treatment outcome, pregnancy, birth and post-partum (fourth trimester care) - including research into interventions aiming to reduce the impact of unconscious bias in clinic care settings. Research proposals in this track should reflect the importance of the patient perspective in study design. 


3. Epidemiology and prevention research; epidemiological studies, including social, lifestyle, exposure and behavioural studies, seeking to understand the origins of racial disparities in IVF access and outcome, pregnancy and maternal health outcomes and ultimately drive solutions to tackle disparities in these areas. 


4. Social science research: Including but not limited to political, policy and human rights research exploring the structural factors that impact on Black communities, Indigenous communities and all communities of colour that contribute to lower than expected outcomes of assisted reproductive technologies (ART), pregnancy and overall maternal and post-partum health, including the barriers to participation in clinical trials. Research proposals in this track should reflect the importance of the patient perspective in study design.


In addition, projects across all research areas exploring racial disparities in COVID-19 infection, hospitalization and health outcomes during pregnancy and birth are also welcomed.


Who should apply?

We encourage submissions from researchers and research organisations around the world who are committed to reducing racial disparities in Reproductive Medicine and Maternal Health. 


Ferring Pharmaceuticals is committed to creating a diverse community and an inclusive culture which embraces, respects and values different perspectives and backgrounds. We encourage researchers from diverse backgrounds to submit applications to the Ferring Innovations Grants Programme for Racial Equality in Reproductive Medicine and Maternal Health. 


Available Funding 

The program will provide a limited number of research grants of up to EUR 20,000 per research project. 


Intellectual Property and license to data and results

Ferring does not intend to claim intellectual property on these grants. Ownership to data and results is assumed by the grant recipient and may be subject to the policies of the grant recipient’s institution. Ferring will be and is hereby granted a worldwide, non-exclusive, royalty-free, right and license (with the right to sublicense) to access, refer to, and otherwise use any and all anonymized research data, information, and other results generated as part of the project (collectively “the Results”) for internal educational, research and development purposes.

Opens
Apr 28 2021 00:00 (CEST)
Deadline
Jul 1 2021 23:59 (CEST)

Categories
Research design, methodology and scientific knowledge gap
Scope - relevance to grant programme objectives
Clarity of research purpose
Potential to address scientific knowledge gap
Potential to report programme relevant data insights after the study
Potential of results to contribute to practice / concrete solutions